← Back to headlines
FDA Accepts Kowa's New Drug Application for Glaucoma Treatment
The U.S. Food and Drug Administration has officially accepted Kowa Pharmaceuticals' new drug application for a novel ophthalmic solution aimed at treating glaucoma.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
